Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

febrile neutropenia

  • You have access
    Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy
    YASUTAKA YAMADA, TOMOKI SHIRAFUJI, KODAI SATO, TAKUYA TSUJINO, SATOSHI YAMAMOTO, TAKAYUKI ARAI, HIROAKI SATO, KOSUKE HIGUCHI, MANATO KANESAKA, NOBUSHIGE TAKESHITA, TAKAAKI TAMURA, TOMOKAZU SAZUKA, YUSUKE IMAMURA, KAZUO MIKAMI, KAZUYOSHI NAKAMURA, SATOSHI FUKASAWA, AKIRA KUROZUMI, NORIYUKI SUZUKI, HARUHITO AZUMA and SHINICHI SAKAMOTO
    Anticancer Research February 2026, 46 (2) 1107-1116; DOI: https://doi.org/10.21873/anticanres.18013
  • You have access
    Machine Learning Model to Guide Empirical Antimicrobial Therapy in Febrile Neutropenic Patients With Hematologic Malignancies
    KOSUKE HOASHI, KOUTAROU MATSUMOTO, JUNICHI KIYASU, TARO SAWABE, MAKOTO OYAMA, MARIKO TSUDA, AKIKO TAKAMATSU, ERIKO FUJIOKA, YUJI YUFU, MOTOAKI SHIRATSUCHI and KENTA MUROTANI
    Anticancer Research June 2025, 45 (6) 2629-2642; DOI: https://doi.org/10.21873/anticanres.17634
  • You have access
    FOLFIRINOX in Pancreatic Cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia — Nationwide Study Analysis
    AKIKO TODAKA, MITSUHITO SASAKI, HIDEKI UENO, TAKUMA GOTO, GOU MUROHISA, NOBUMASA MIZUNO, MASATO OZAKA, SATOSHI KOBAYASHI, KAZUHIRO UESUGI, NORITOSHI KOBAYASHI, HIDEYUKI HAYASHI, KENTARO SUDO, NAOHIRO OKANO, YOSUKE HORITA, KEIKO KAMEI, SHOKO NANAMI and NARIKAZU BOKU
    Anticancer Research September 2023, 43 (9) 4115-4123; DOI: https://doi.org/10.21873/anticanres.16601
  • You have access
    Efficacy and Cost-effectiveness of Pegfilgrastim for Preventing Febrile Neutropenia During Docetaxel, Cisplatin, and 5-Fluorouracil Therapy for Esophageal Cancer
    TAKANORI KUROGOCHI, AKIRA MATSUMOTO, YUYA NYUMURA, YUICHIRO TANISHIMA, TOMOKO NAKAYOSHI, TOMOYOSHI OKAMOTO, FUMIAKI YANO and KEN ETO
    Anticancer Research May 2023, 43 (5) 2293-2298; DOI: https://doi.org/10.21873/anticanres.16393
  • You have access
    Poor Renal Function and a High Modified Glasgow Prognostic Score Are Predictive Factors for Nedaplatin/5-Fluorouracil Combination Therapy-induced Febrile Neutropenia
    JUNYA HASHIZUME, MADOKA NAMBU, HIROO NAKAGAWA, HITOMI HARASAWA and YUKINOBU KODAMA
    Anticancer Research May 2023, 43 (5) 2309-2316; DOI: https://doi.org/10.21873/anticanres.16395
  • You have access
    Half Dose Pegfilgrastim for Patients With Breast Cancer During Chemotherapy: A Case-series
    MAKO IKEDA, YUKI KATAOKA, TOMOE TAJI, HIROFUMI SUWA and HIDEKO NAKAGOSHI
    Anticancer Research March 2023, 43 (3) 1373-1375; DOI: https://doi.org/10.21873/anticanres.16285
  • You have access
    Clinical Verification on the Predictors for Febrile Neutropenia in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
    WATARU GOTO, SHINICHIRO KASHIWAGI, KOHEI MATSUOKA, NOZOMI IIMORI, RIKA KOUHASHI, AKIMICHI YABUMOTO, KOJI TAKADA, YUKA ASANO, YUKIE TAUCHI, KANA OGISAWA, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA and KIYOSHI MAEDA
    Anticancer Research January 2023, 43 (1) 247-254; DOI: https://doi.org/10.21873/anticanres.16156
  • You have access
    Effect of Secondary Prophylactic G-CSF on the Occurrence of Febrile Neutropenia in Breast Cancer
    KANAKO SUZUKI, SHINSUKE SASADA, YURI KIMURA, AKIKO EMI, TAKAYUKI KADOYA and MORIHITO OKADA
    Anticancer Research December 2022, 42 (12) 5945-5949; DOI: https://doi.org/10.21873/anticanres.16104
  • You have access
    Predictive Factors of Febrile Neutropenia After Primary Prophylactic Pegfilgrastim With DCF Chemotherapy for Esophageal Cancer
    TAKAHITO INAGAKI, MIKI SATO, MASAOKI KIN, KOJI OTSUKA, MASAHIKO MURAKAMI and MARI KOGO
    Anticancer Research December 2022, 42 (12) 6071-6081; DOI: https://doi.org/10.21873/anticanres.16119
  • You have access
    Primary Prophylaxis of Febrile Neutropenia With Pegfilgrastim in Small-cell Lung Cancer Patients Receiving Amrubicin as Second-line Therapy
    YUKINA SATO, HIROTOSHI IIHARA, MOTOHIKO KINOMURA, CHIEMI HIROSE, HIRONORI FUJII, JUNKI ENDO, KOMEI YANASE, DAIZO KAITO, YUKA SASAKI, TAKENOBU GOMYO, CHIZURU SAKAI, MASAMICHI IWAI, YOSHIKI TSUBOI, TAKUMA ISHIHARA, RYO KOBAYASHI, YASUSHI OHNO and AKIO SUZUKI
    Anticancer Research March 2021, 41 (3) 1615-1620; DOI: https://doi.org/10.21873/anticanres.14923

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire